Marimed targets New York launch in H1 2027 with $4B market opportunity as record $44.2M quarter extends momentum
· seekingalpha.com
MariMed posts record Q3 2026 revenue of $44.2 million, up 8.5% year over year, with $4.7 million adjusted EBITDA and $3.5 million operating cash flow.
Earnings Call Insights Marimed targets New York launch in H1 2027 with $4B market opportunity as record $44.2M quarter extends momentum Nov 12, 2026, 12:30 PM E...